First Light Asset Management’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
2023
Q2
$146M Sell
2023
Q1
$144M Sell
2022
Q4
$78.4M Buy
2022
Q3
$26.5M Buy